Stone Christopher Lewis 4
4 · PDL BIOPHARMA, INC. · Filed Sep 27, 2018
Insider Transaction Report
Form 4
Stone Christopher Lewis
VP and General Counsel
Transactions
- Award
Stock Option (right to buy)
2018-09-25+339,623→ 339,623 totalExercise: $2.52Exp: 2028-09-25→ Common stock (339,623 underlying)
Footnotes (1)
- [F1]The stock options will vest on a monthly basis pro rata over the 48 months following January 1, 2018, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance agreement between the issuer and the recipient.